Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral Palsy
CompletedPhase 4NCT06583343
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study is to investigate the effects of Botulinum Neurotoxin-A (BoNT-A) injection applied to spastic muscles on pain sensation and Selective Motor Control (SMC) in cases diagnosed with diplegic spastic Cerebral Palsy.
Study details
- Official title
- Effects of Botulinum Toxin A on Selective Motor Control in Cerebral Palsy: A Simultaneous Assessment of Upper and Lower Extremities
- Conditions
- Cerebral Palsy Spastic Diplegia
- Interventions
- Drug: OnabotulinumtoxinA
- Other: Conventional Physical Therapy
- Sponsor
- Gaziosmanpasa Research and Education Hospital
- Start date
- 2022-08-25
- Primary completion
- 2023-05-25
- Sex
- All
- Age range
- from 4 Years to 12 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients diagnosed with Cerebral Palsy * Between the ages of 4-12 * GMFCS (Gross Motor Function Classification System)1-4 * Patients who have received an appropriate indication for BoNT-A injection from an experienced physiatrist * Patients who have not had botulinum toxin administered in the last 6 months Exclusion Criteria: * Mental retardation * GMFCS 5 * Have an intrathecal baclofen pump for spasticity treatment or history of soft tissue and/or bone surgery * Underwent dorsal rhizotomy * Have an active infection or a localized skin infection at the injection site * Using aminoglycoside antibiotics * Contracture
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06583343